| |
 |
|
|
|
|
|
Poster: 177
Visits: 126
Title: Healthcare utilization in the AETHERA trial: phase 3 study of brentuximab vedotin in patients at increased risk of residual Hodgkin lymphoma post ASCT
Authors: vijayveer bonthapally ,
Centre: Hospital Clínic
|
|
You must be registered to reply or comment.
|
|
HEALTHCARE UTILIZATION IN THE AETHERA TRIAL: PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN IN PATIENTS AT INCREASED RISK OF RESIDUAL HODGKIN LYMPHOMA POST ASCT
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 10
Visits: 365
Title: Efficacy and Safety of Lenalidomide and Rituximab vs Placebo and Rituximab in a Phase 3 Trial in Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: John Leonard , Marek Trne&711;n, Phillip Scheinberg, Kensei Tobinai, Nathan H. Fowler, Nurgul Kilavuz, Pierre Fustier, Barbara Amoroso, and John G. Gribben
Centre: Weill Cornell Medical College,
|
|
|
|
